YE
Table 1 (cont'd)
Est.
Pt. No.
& sex
Age
1979
thyroid
dose
(rads)
Thyroid Nodularities
Age at
detection
Surgery
Hypofunction
Diagnosis
TSH (w/d1)
(c)} Rongelap exposed at age >18
18 F
45
335
4M
63
335
64 F
55
335
78 F
62
335
66 F
55
335
71 F
34 F
52
70
335
335
34
41
Cleve. '69
Bost. '65
Papillary Ca
Papillary Ca
6.0, 7.0
6.6, 8.8
55
Cleve. '79
Adenomatous nod.
Cleve. ‘72
Cleve. '81
Adenomatous nod.
Occult Pap. Ca
6.5, 7.0
6.3, 8.3
(d) Ailingnae exposed at age <10
8F
53 F
26
33
450
320
18
28
(e) Ailingnae exposed at age 10-18:
and adenomatous nod.
NONE
(£) Ailingnae exposed at age >18
51 F
50
135
45 F
57
135
59 F
_—
135
16 M
64
41 M
69
135
45
Cleve.
‘74
51
Cleve. '73
53
Bost. '66
135
Adenoma
Adenomatcous nod.
Nodule
Adenomatous nod.
(died '68, age 54)
6.4, 6.5
(g) Utirik exposed at age <10
2160 F
2154 F
31
29
80
75
28
25
Cleve. ‘75
2147 F
2239 F
26
28
90
80
25
28
Cleve. ‘79
Cleve. ‘81
2132 F
27
80
27
Cleve. ‘81
Papillary Ca
Nodule
reduced ‘79
Adenomatous nod.
"
"
"
"
(h) Utirik exposed at age 10-18
2150 M
2229 F
37
43
54
31
33
32
Cleve. ‘76
Cleve. ‘69
2236 M
36
55
34
Hono. ‘78
- 126 +
Adenoma
Papillary Ca
vs. atypical adenoma
Adenoma